✦ LIBER ✦

Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis

✍ Scribed by Gerda Rudolph; Richard Endele; Martin Senn; Adolf Stiehl

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 503 KB
Volume: 17
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840170614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ursodeoxycholic acid and chen

Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture

✍ Sophie Hillaire; François Ballet; Dominique Franco; Kenneth D. R. Setchell; Raou 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Hepatic bile acid concentrations are elevated in chronic cholestasis because of reduced canalicular excretion and active ileal absorption of the fraction eliminated in the gut. Ursodeoxycholic acid (UDCA) reduces the intestinal absorption of endogenous bile acids, thereby diminishing the concentrati

Effect of high-dose ursodeoxycholic acid

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

✍ Daniel Rost; Gerda Rudolph; Petra Kloeters-Plachky; Adolf Stiehl 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. In primary sclerosing cholangitis (PSC), there is evidence that high doses (؎20 mg/kg) of UDCA may be more effective than average doses. Biliary enrichment of UDCA at such high doses may represent the decisive factor f

High-dose ursodeoxycholic acid for the t

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve

Effect of simvastatin, ursodeoxycholic a

Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia

✍ Giuseppe Mazzella; Paolo Parini; Davide Festi; Franco Bazzoli; Rita Aldini; Aldo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Impact of inflammatory bowel disease and

Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis

✍ Phunchai Charatcharoenwitthaya; Paul Angulo; Felicity B. Enders; Keith D. Lindor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 2 views

A longitudinal, cohort study was performed to characterize the clinical features of patients with small-duct primary sclerosing cholangitis (PSC) occurring with and without inflammatory bowel disease (IBD) and to determine the influence of IBD and the effect of ursodeoxycholic acid (UDCA) therapy on

High-dose ursodeoxycholic acid in the tr

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: Throwing the urso out with the bathwater?

✍ Roger W. Chapman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views